Provided by Tiger Fintech (Singapore) Pte. Ltd.

Jazz Pharmaceuticals PLC

98.41
-3.0300-2.99%
Post-market: 99.000.5900+0.60%17:29 EDT
Volume:2.22M
Turnover:219.24M
Market Cap:5.98B
PE:13.11
High:104.06
Open:101.58
Low:97.50
Close:101.44
Loading ...

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Market Exclusive
·
13 Jan

Analysts Offer Insights on Healthcare Companies: Sotera Health (SHC), Jazz Pharmaceuticals (JAZZ) and Karyopharm Therapeutics (KPTI)

TIPRANKS
·
10 Jan

RBC Capital Reaffirms Their Buy Rating on Jazz Pharmaceuticals (JAZZ)

TIPRANKS
·
10 Jan

Zymeworks Sees Current Cash Resources, Expected Payments to Support Operations Into H2 2027

MT Newswires Live
·
09 Jan

Analysts Offer Insights on Healthcare Companies: Jazz Pharmaceuticals (JAZZ), Natera (NTRA) and Neumora Therapeutics, Inc. (NMRA)

TIPRANKS
·
03 Jan

Jazz Pharmaceuticals (JAZZ) Gets a Buy from TD Cowen

TIPRANKS
·
17 Dec 2024

Jazz Pharma's Bruce Cozadd to Retire as CEO

Dow Jones
·
17 Dec 2024

BRIEF-Jazz Pharmaceuticals Announces CEO Succession Plan

Reuters
·
17 Dec 2024

Jazz Pharmaceuticals CEO Bruce Cozadd Plans to Retire

MT Newswires Live
·
17 Dec 2024

Jazz Pharmaceuticals CEO Bruce Cozadd to retire by end of 2025

TIPRANKS
·
17 Dec 2024

Jazz Pharmaceuticals 'On Track to Meet its Full Year 2024 Revenue Guidance' of $4.0-$4.1 Billion

MT Newswires Live
·
17 Dec 2024

Jazz Pharmaceuticals Announces CEO Succession Plan

THOMSON REUTERS
·
17 Dec 2024

Jazz Pharmaceuticals Plc - on Track to Meet 2024 Revenue Guidance of $4.0-$4.1 Billion

THOMSON REUTERS
·
17 Dec 2024

Jazz Pharmaceuticals Plc - Bruce Cozadd to Retire as CEO by End of 2025

THOMSON REUTERS
·
17 Dec 2024

Press Release: Jazz Pharmaceuticals Announces CEO Succession Plan

Dow Jones
·
17 Dec 2024

Truist Securities Adjusts Jazz Pharmaceuticals Public Price Target to $220 From $200, Maintains Buy Rating

MT Newswires Live
·
16 Dec 2024

Analysts Conflicted on These Healthcare Names: Jazz Pharmaceuticals (JAZZ), Acadia Healthcare (ACHC) and Genmab (GMAB)

TIPRANKS
·
16 Dec 2024

Jazz Pharmaceuticals Plc : Truist Securities Raises Target Price to $220 From $200

THOMSON REUTERS
·
16 Dec 2024

Is Now The Time To Put Jazz Pharmaceuticals (NASDAQ:JAZZ) On Your Watchlist?

Simply Wall St.
·
14 Dec 2024

Jazz upgraded to Overweight at Morgan Stanley after Ziihera launch

TipRanks
·
13 Dec 2024